• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·600299.SS
Share

Bluestar Adisseo Company Stocks

CN¥ 11.49Last Updated 26.05.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

CN¥ 5.10B

CN¥ 11.49
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Bluestar Adisseo Company engages in the research, development, production, and sale of feed additives for animal nutrition worldwide. The company's products include Rhodimet, a methionine solution for monogastric animals that is available in solid and liquid forms, such as Rhodimet NP99 and Rhodimet AT88; nutrition solutions comprising Smartamine and MetaSmart for amino acid balancing in lactating dairy cow ration formulation, as well as for dairy cows and other ruminants; and Microvit, a range of vitamins for the feed industry. It also offers Rovabio, a range of enzyme preparations that enhance the digestibility of raw materials from vegetal origin for animals, poultry, and hogs; and Selisseo 2% Se, a source of organic selenium that is based on seleno-hydroxy-methionine for use in animal feed. In addition, the company provides AdiSodium, a source of chloride-free sodium that offers a solution for dietary electrolyte balance in monogastric feeds and supplies sulphur in assimilated form to ruminant feeds; and Alterion for enhancing the animal intestinal micro ecological environment and the production performance of animal. Further, it offers PNE, a service based on NIR technology to predict the nutritional quality of the raw materials used in feed; DiM, a service and assistance program for Rhodimet AT88 applications; and E-lab, a web service that allows customers to post analytical requests and identify samples prior to shipping them to Adisseo laboratory. The company was founded in 1939 and is based in Beijing, China. Bluestar Adisseo Company is a subsidiary of China National Bluestar (Group) Co., Ltd.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.05.2026 20:26

Michael Kors owner expects profit growth at the expense of youth. What about the stock?

27.05.2026 19:25

Goldman predicted a 17% rise in the S&P 500 in 2026. Why did it improve its forecast?

27.05.2026 18:51

Iran promised to open the Strait of Hormuz within a month of the deal. What's in the markets?

27.05.2026 18:17

Trump risks triggering financial crisis with war with Iran, ECB warned

27.05.2026 17:27

Analyst says 'don't bother' with pot stock Tilray, even after Trump's rescheduling

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026